If that was true there would be a lot of insider buying. They are putting in place the pieces for rapid commercialisation should the trials be successful. It also puts pressure on major pharma who no doubt are following developments. They will be in no doubt that the company management can do what they say they will.
If that was true there would be a lot of insider buying. They...
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
61.0¢ |
Change
-0.010(1.61%) |
Mkt cap ! $404.3M | |||
| Open | High | Low | Value | Volume |
| 62.5¢ | 62.5¢ | 60.5¢ | $208.1K | 341.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2890 | 61.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 62.0¢ | 3370 | 1 |
View Market Depth
| Last trade - 16.10pm 02/05/2024 (20 minute delay) ? |
|
|||||
|
Last
61.5¢ |
Change
-0.010 ( 0.69 %) |
||||
| Open | High | Low | Volume | ||
| 62.0¢ | 62.0¢ | 60.5¢ | 17553 | ||
| Last updated 15.59pm 02/05/2024 ? | |||||
| OPT (ASX) Chart |